Active Research Project
Investigator(s):
Mony de Leon, Ed.D.
Related Institute:
Last Updated:
June 14, 2022
Awards or Grants: 2R44AG044860-04, National Institutes of Health (NIH) (03/01/17-02/28/23)
The main objective of this collaborative project is to assess the microRNA-based assay performance for the detection of mild cognitive impairment, Alzheimer's disease (AD), pre-symptomatic AD (cognitively normal, amyloid-positive) and control (cognitively normal, amyloid-negative) using ethylenediaminetetraacetic acid (EDTA) plasma samples collected at the Center for Brain Health, New York University School of Medicine, and processed with an optimized protocol and microRNA signatures.